According to the study findings, the RCS/SF scaffold applied topically has the ability to successfully decrease hepatic lipid buildup, inflammation, and oxidative stress by activating the AMPK signalling pathway, leading to an overall improvement in NAFLD in db/db mice (Fig. 9). This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.